Position in PBYI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,426,855
+$1,147,351 QoQ
Shares Held
669,156
-0.1% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Derivatives in PBYI
reported options exposure · as of Mar 31, 2020CallValue
$627,092
CallShares
74,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. PBYI ranks #189 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in PBYI
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,426,855 | 669,156 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,279,504 | 669,719 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,724,073 | 793,962 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,245,815 | 234,617 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $692,958 | 202,029 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $870,958 | 294,243 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $957,995 | 314,097 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $779,579 | 305,718 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $653,903 | 200,584 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,388,073 | 450,580 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $502,084 | 115,955 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $221,298 | 84,144 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $260,915 | 73,914 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $228,671 | 74,004 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $323,386 | 76,451 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $283,289 | 119,532 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $629,541 | 220,892 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,266,721 | 439,834 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,940,821 | 2,283,165 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $5,663,561 | 807,926 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,548,620 | 386,560 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,023,490 | 825,462 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,160,791 | 697,933 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $9,152,436 | 907,080 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,270,212 | 984,680 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $627,092 | 74,300 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $5,852,742 | 693,453 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||